Log in
Enquire now
‌

US Patent 8999325 Treatment of ocular disease

Patent 8999325 was granted and assigned to Aerpio Therapeutics on April, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Aerpio Therapeutics
Aerpio Therapeutics
Current Assignee
Aerpio Therapeutics
Aerpio Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8999325
Patent Inventor Names
Kevin Peters0
Robert Shalwitz0
Date of Patent
April 7, 2015
Patent Application Number
13652154
Date Filed
October 15, 2012
Patent Citations Received
‌
US Patent 12064420 Tie-2 activators targeting the Schlemm's canal
0
‌
US Patent 11666558 Methods of treating intraocular pressure with activators of Tie-2
0
‌
US Patent 11873334 Method of treating ocular conditions by administering an antibody that activates Tie2 and binds VEGF
0
0
Patent Primary Examiner
‌
Phuong Huynh
Patent abstract

Disclosed are methods for treating eye diseases or conditions characterized by vascular instability, vascular leakage and neovacularization such as diabetic macular edema, age-related macular edema, choroidal neovascularization, diabetic retinopathy, trauma, ocular ischemia, retinal angiomatous proliferation, macular telangiectasia and uveitis.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8999325 Treatment of ocular disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.